from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0274/-

LFCtreatmentdescriptionclass of inhibitor

-0.255

Amikacinug/mL Amikacintranslation

-0.163

Cap5-10ug/mL Capreomycintranslation

0.527

Rox10-50 ug/mL Roxithromycintranslation

-1.117

SM2-5 ug/mL Streptomycintranslation

-1.280

Tet5-10 ug/mL Tetracyclinetranslation

0.004

Rif0.2-5ug/mL Rifampicintranscription

-0.520

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.128

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.248

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.075

CPZ10-50 ug/mL Chlorpromazinerespiration

0.363

Clofazimine10-13 ug/mL Clofaziminerespiration

0.026

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.226

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.213

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.104

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.031

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.500

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.375

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.130

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.632

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.174

KCN5-20 ug/mL Potassium cyaniderespiration

-0.420

NaN30.2-2 mM Sodium aziderespiration

0.216

Nigericin50 uM Nigericinrespiration

0.454

TRC10-150 ug/mL Triclosanrespiration

1.717

TRZ10-25 ug/mL Thioridazinerespiration

1.321

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.084

menadione6-10 ug/mL Menadionerespiration

-0.465

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.503

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.198

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.455

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.104

NRP_1Non-replicating persistence stage 1dosRassociated

-0.698

Amp0.2mg/mL AmpicillincellWall

-0.528

Cephalexin20-100 ug/mL CephalexincellWall

-0.456

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.783

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.593

EMB10-20 ug/mL EthambutolcellWall

-0.624

Eta12-40 ug/mL EthionamidecellWall

-0.621

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.553

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.299

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.318

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.706

BZA0.12 mg/mL BenzamidearomaticAmides

0.323

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.669

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.092

H2O24 mM hydrogen peroxideDNAdamaging

-0.346

Levo10 ug/mL LevofloxacinDNAdamaging

-0.452

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.332

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.493

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.632

UVUV-irradiationDNAdamaging

0.003

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.707

Antimycin12.5-50 ug/mL Antimycin A?

-0.396

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.104

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.009

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.366

PA8240.2-2 ug/mL PA-824?

1.225

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.050

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.512

Verapamil50 uM Verapamil?

-0.107

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.597

methoxatin10-20 ug/mL Methoxatin?